| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35a08bb718da0b231f9f5d570466c0ab |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 |
| filingDate |
2015-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb6b8ccf890e6934cfd88ef884094aff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd0cae4b10e42ce72812b0b7a71928a5 |
| publicationDate |
2016-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2979693-A1 |
| titleOfInvention |
Pharmaceutical composition comprising prasugrel or pharmaceutically acceptable salt thereof and process for its preparation |
| abstract |
The present invention relates to a pharmaceutical composition comprising prasugrel or pharmaceutically acceptable salt thereof, preferably for oral administration, with increased stability and process for its preparation. |
| priorityDate |
2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |